IL-15 Reprogramming Compensates for NK Cell Mitochondrial Dysfunction in HIV-1 Infection
Overview
General Medicine
Authors
Affiliations
Dynamic regulation of cellular metabolism is important for maintaining homeostasis and can directly influence immune cell function and differentiation, including NK cell responses. Persistent HIV-1 infection leads to a state of chronic immune activation, NK cell subset redistribution, and progressive NK cell dysregulation. In this study, we examined the metabolic processes that characterize NK cell subsets in HIV-1 infection, including adaptive NK cell subpopulations expressing the activating receptor NKG2C, which expand during chronic infection. These adaptive NK cells exhibit an enhanced metabolic profile in HIV-1- individuals infected with human cytomegalovirus (HCMV). However, the bioenergetic advantage of adaptive CD57+NKG2C+ NK cells is diminished during chronic HIV-1 infection, where NK cells uniformly display reduced oxidative phosphorylation (OXPHOS). Defective OXPHOS was accompanied by increased mitochondrial depolarization, structural alterations, and increased DRP-1 levels promoting fission, suggesting that mitochondrial defects are restricting the metabolic plasticity of NK cell subsets in HIV-1 infection. The metabolic requirement for the NK cell response to receptor stimulation was alleviated upon IL-15 pretreatment, which enhanced mammalian target of rapamycin complex 1 (mTORC1) activity. IL-15 priming enhanced NK cell functionality to anti-CD16 stimulation in HIV-1 infection, representing an effective strategy for pharmacologically boosting NK cell responses.
Elephant in the room: natural killer cells don't forget HIV either.
Jost S, Reeves R Curr Opin HIV AIDS. 2025; 20(2):109-116.
PMID: 39773904 PMC: 11802307. DOI: 10.1097/COH.0000000000000909.
Wang Y, Guo A, Yang L, Han X, Li Q, Liu J Mol Cell Biochem. 2024; .
PMID: 39663335 DOI: 10.1007/s11010-024-05181-z.
The Role of Natural Killer Cells and Their Metabolism in HIV-1 Infection.
Naidoo K, Altfeld M Viruses. 2024; 16(10).
PMID: 39459918 PMC: 11512232. DOI: 10.3390/v16101584.
Batohi N, Shalekoff S, Shalekoff S, Martinson N, Ebrahim O, Tiemessen C J Acquir Immune Defic Syndr. 2024; 97(5):522-532.
PMID: 39219024 PMC: 11540281. DOI: 10.1097/QAI.0000000000003518.
Alterations in mitochondrial morphology as a key driver of immunity and host defence.
Cervantes-Silva M, Cox S, Curtis A EMBO Rep. 2021; 22(9):e53086.
PMID: 34337844 PMC: 8447557. DOI: 10.15252/embr.202153086.